SCHEMBL8907704

SCHEMBL8907704

Oc1cccc(C2=C3C=CC(=N3)C(c3cccc(O)c3)=c3ccc([nH]3)=C(c3cccc(O)c3)C3=NC(=C(c4cccc(O)c4)C4CCC2N4)C=C3)c1

nearest known ligand 0.32

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCNB3 Q8WWL7 1/20 0.32
▸ HSD17B1 P14061 3/20 0.31
▸ HSD17B2 P37059 3/20 0.31
▸ IDH1 O75874 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10524556 1.00 CCNB2 (0.32) CCNB2CDK1CCNB1CCNB3HSD17B1
SCHEMBL8908351 0.85 CHRNB4 (0.31) HSD17B1HSD17B2IDH1SLC6A3
SCHEMBL5104033 0.85 CHRNB4 (0.31) HSD17B1HSD17B2IDH1SLC6A3
SCHEMBL9559701 0.84 SLC6A3 (0.30) SLC6A3
SCHEMBL5016512 0.84 — —
SCHEMBL10525261 0.84 — —
SCHEMBL9559683 0.75 — —
SCHEMBL8676968 0.73 — —
SCHEMBL6260570 0.73 — —
SCHEMBL249200 0.73 HSD17B1 (0.47) CCNB2CDK1CCNB1CCNB3HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0337601-B1 PORPHYRINS AND MEDICAMENTS FOR CANCER TREATMENT SCOTIA HOLDINGS PLC (GB) 1993-05-05 — — EP claimed
US-4992257-A Dihydroporphyrins and method of treating tumors EFAMOL HOLDINGS PLC (GB) 1991-02-12 — — US claimed
EP-0337601-A1 Porphyrins and medicaments for cancer treatment SCOTIA HOLDINGS PLC (GB) 1989-10-18 — — EP claimed
US-12178907-B2 Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-12-31 — — US disclosed
US-20220142922-A1 LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME THE GENERAL HOSPITAL CORPORATION 2022-05-12 — — US disclosed
EP-3302436-A1 LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME The General Hospital Corporation (US) 2018-04-11 — — EP disclosed
WO-2016191556-A1 LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME THE GENERAL HOSPITAL CORPORATION (US) 2016-12-01 — — WO disclosed
WO-2012076631-A1 SYSTEM AND METHOD FOR INTERSTITIAL PHOTODYNAMIC LIGHT THERAPY IN COMBINATION WITH PHOTOSENSITIZERS SPECTRACURE AB (SE) 2012-06-14 — — WO disclosed
EP-0758331-A1 POLYETHYLENE GLYCOL DERIVATISED DIHYDRO OR TETRAHYDRO PORPHYRINS, THEIR PREPARATION AND THEIR USE AS TUMOUR LOCALISING, PHOTOSENSITISING COMPOUNDS SCOTIA HOLDINGS PLC (GB) 1997-02-19 — — EP disclosed
WO-1995029915-A1 POLYETHYLENE GLYCOL DERIVATISED DIHYDRO OR TETRAHYDRO PORPHYRINS, THEIR PREPARATION AND THEIR USE AS TUMOUR LOCALISING, PHOTOSENSITISING COMPOUNDS SCOTIA HOLDINGS PLC (GB) 1995-11-09 — — WO disclosed
EP-0337601-B1 PORPHYRINS AND MEDICAMENTS FOR CANCER TREATMENT SCOTIA HOLDINGS PLC (GB) 1993-05-05 — — EP disclosed
US-5162519-A Porphyrins and cancer treatment EFAMOL HOLDINGS PLC (GB) 1992-11-10 — — US disclosed
US-4992257-A Dihydroporphyrins and method of treating tumors EFAMOL HOLDINGS PLC (GB) 1991-02-12 — — US disclosed
EP-0337601-A1 Porphyrins and medicaments for cancer treatment SCOTIA HOLDINGS PLC (GB) 1989-10-18 — — EP disclosed
Send feedback